SLC5A2 and neoplasm: Research findings indicate (Scafoglio et al., 2018) that SGLT-2 exhibits specific expression in premalignant and highly differentiated lung carcinomas, whereas precancerous and early lung adenocarcinomas predominantly rely on SGLT-2 for glucose transport into the tumor.